Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Huma

Explore full profile

Provides a digital health platform used for predictive care and research

London, United KingdomFounded 2011Biotech & Life Sciences
Valuation $250–500M Last recorded · 2026
Revenue $10–50M Latest reported FY
Headcount 100–500 Current team size
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Huma and the history behind them.

At a glance

Founded
2011
Headquarters
London, United Kingdom
Sector
Biotech & Life Sciences
Power Law
Colt$25–100M revenue

Latest news

Press, funding announcements and product moves mentioning Huma.

See all news

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • Iratel Ventures
  • Dale Ventures
  • Healthbox

Series A1 investor entered at this stage

  • NWS Holdings

Series B and later11 investors entered at this stage

  • Michael Diekmann
  • HAT SGR
  • Unilever Ventures
  • Tech Nation
  • Nikesh Arora
  • Bayer
  • AstraZeneca
  • Sony Innovation Fund
  • Samsung Next
  • Leaps by Bayer
  • Hitachi
Employees mapped 284 incl. 7 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 12 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 10 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇬🇧 United Kingdom · London HQ
Book a demo for the full country breakdown
Web traffic by country
33K monthly visits
across markets
🇬🇧 United Kingdom17%
🇺🇸 United States14.8%
🇳🇴 Norway10.9%
🇦🇺 Australia10%
🇨🇦 Canada9.4%
Top 5 markets shown

Investments and acquisitions

Disclosed deals where Huma was the backer or acquirer, 2018–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

6 deals across Huma's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Huma's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        6 of 6 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Huma on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Huma on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.